Systems biology study of Huntington's disease DOI
Leonardo E. Dionisio, Peter Langfelder,

Jeffrey S. Aaronson

et al.

Elsevier eBooks, Journal Year: 2024, Volume and Issue: unknown, P. 353 - 396

Published: Jan. 1, 2024

Language: Английский

Aberrant splicing in Huntington’s disease accompanies disrupted TDP-43 activity and altered m6A RNA modification DOI Creative Commons
Thai B. Nguyen, Ricardo Miramontes,

Carlos Chillón-Marinas

et al.

Nature Neuroscience, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 6, 2025

Language: Английский

Citations

2

Distinct mismatch-repair complex genes set neuronal CAG-repeat expansion rate to drive selective pathogenesis in HD mice DOI Creative Commons
Nan Wang, Shasha Zhang, Peter Langfelder

et al.

Cell, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 1, 2025

Highlights•Mismatch-repair genes drive striatal and cortical neuronal pathogenesis in HD mice•Linear rate of CAG expansion neurons is dependent on Msh3 Pms1•Somatic elicits repeat-length -threshold-dependent pathologies•Msh3 deficiency corrects synaptic, astrocytic, locomotor defects miceSummaryHuntington's disease (HD) modifiers include mismatch-repair (MMR) genes, but their connections to remain unclear. Here, we genetically tested 9 genome-wide association study (GWAS)/MMR mutant Huntingtin (mHtt) mice with 140 inherited repeats (Q140). Knockout (KO) encoding a distinct MMR complex either strongly (Msh3 Pms1) or moderately (Msh2 Mlh1) rescues phenotypes early onset medium-spiny (MSNs) late the neurons: somatic CAG-repeat expansion, transcriptionopathy, mHtt aggregation. ameliorates open-chromatin dysregulation Q140 neurons. Mechanistically, fast linear modal-CAG-repeat MSNs (8.8 repeats/month) drastically reduced stopped by mutants. Pms1 prevents aggregation keeping MSN length below 150. Importantly, mice. Thus, CAG-expansion rates HD-vulnerable elicit repeat-length/threshold-dependent, selective, progressive vivo.Graphical abstract

Language: Английский

Citations

1

Oligodendrocyte pathology in Huntington’s disease: from mechanisms to therapeutics DOI Open Access
Costanza Ferrari Bardile, Carola I. Radulescu, Mahmoud A. Pouladi

et al.

Trends in Molecular Medicine, Journal Year: 2023, Volume and Issue: 29(10), P. 802 - 816

Published: Aug. 15, 2023

Language: Английский

Citations

16

Glial cells: an important switch for the vascular function of the central nervous system DOI Creative Commons

Ling Gao,

Xuezhen Pan,

John H. Zhang

et al.

Frontiers in Cellular Neuroscience, Journal Year: 2023, Volume and Issue: 17

Published: May 3, 2023

In this review, we first describe the current understanding of glial-mediated vascular function affecting role blood-brain barrier (BBB) in central nervous system (CNS) disorders. BBB, mainly composed glial and endothelial cells (ECs), is protective structure that orchestrates transport substances, including ions, molecules, from brain vessels into or out CNS. Then, display multiple communication between based on angiogenesis, wrapping, blood perfusion brain. Glial can support microvascular ECs to form a network connecting neurons. Astrocytes, microglia, oligodendrocytes are common types surrounding vessel. Glial-vessel interaction required for permeability integrity BBB. cerebral transmit signals regulate activity growth factor (VEGF) Wnt-dependent angiogenesis mechanism. addition, these monitor flow via Ca

Language: Английский

Citations

14

Aberrant splicing in Huntington’s disease via disrupted TDP-43 activity accompanied by altered m6A RNA modification DOI Open Access
Thai B. Nguyen, Ricardo Miramontes,

Carlos Chillón-Marinas

et al.

bioRxiv (Cold Spring Harbor Laboratory), Journal Year: 2023, Volume and Issue: unknown

Published: Nov. 2, 2023

Abstract Huntington’s disease (HD) is a neurodegenerative disorder caused by CAG repeat expansion in the first exon of HTT gene encoding huntingtin. Prior reports have established correlation between expanded and altered expression. However, mechanisms leading to disruption RNA processing HD remain unclear. Here, our analysis reported protein interactome identifies interactions with known RNA-binding proteins (RBPs). Total, long-read sequencing targeted RASL-seq RNAs from cortex striatum mouse model R6/2 reveals increased skipping which confirmed Q150 Q175 knock-in mice human brain. We identify RBP TDP-43 N6-methyladenosine (m6A) writer methyltransferase 3 (METTL3) be upstream regulators HD. Along this novel mechanistic insight, we observe decreased nuclear localization cytoplasmic accumulation phosphorylated In addition, co-localizes brain forming aggregate-like bodies distinct mutant inclusions or previously observed pathologies. Binding onto HD-associated differentially expressed aberrantly spliced genes decreased. Finally, m6A modification reduced on abnormally brain, including at clustered sites adjacent binding sites. Our evidence supports loss function coupled as mechanism underlying alternative splicing/unannotated usage highlights critical nature across multiple diseases.

Language: Английский

Citations

13

Single-Cell Sequencing in Neurodegenerative Disorders DOI Creative Commons
Jelena Pozojevic, Malte Spielmann

Molecular Diagnosis & Therapy, Journal Year: 2023, Volume and Issue: 27(5), P. 553 - 561

Published: Aug. 8, 2023

Neurodegenerative disorders are typically characterized by late onset progressive damage to specific (sub)populations of cells the nervous system that essential for mobility, coordination, strength, sensation, and cognition. Addressing this selective cellular vulnerability has become feasible with emergence single-cell-omics technologies, which now represent state-of-the-art approach profile heterogeneity complex tissues including human post-mortem brain at unprecedented resolution. In review, we briefly recapitulate experimental workflow single-cell RNA sequencing summarize recent knowledge acquired it in most common neurodegenerative diseases: Parkinson's, Alzheimer's, Huntington's disease, multiple sclerosis. We also discuss possibility applying approaches diagnostics therapy disorders, as well limitations. While currently point deeply exploring transcriptomic changes affected cells, further technological developments hold a promise manipulating pathways once understand them better.

Language: Английский

Citations

12

Association of vitamin B1 intake with geriatric cognitive function: An analysis of the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2014 DOI Creative Commons

Kangkang Ji,

Minli Sun,

Hong Ye

et al.

Heliyon, Journal Year: 2024, Volume and Issue: 10(7), P. e28119 - e28119

Published: April 1, 2024

The association between dietary vitamin B1 intake and cognitive performance in the noninstitutionalized older adult population of United States remains unclear.

Language: Английский

Citations

4

Multi-omic analysis of Huntington’s disease reveals a compensatory astrocyte state DOI Creative Commons
Fahad Paryani,

Ji‐Sun Kwon,

Christopher Ng

et al.

Nature Communications, Journal Year: 2024, Volume and Issue: 15(1)

Published: Aug. 8, 2024

The mechanisms underlying the selective regional vulnerability to neurodegeneration in Huntington's disease (HD) have not been fully defined. To explore role of astrocytes this phenomenon, we used single-nucleus and bulk RNAseq, lipidomics, HTT gene CAG repeat-length measurements, multiplexed immunofluorescence on HD control post-mortem brains. We identified genes that correlated with repeat length, which were enriched astrocyte genes, lipidomic signatures implicated poly-unsaturated fatty acids sensitizing neurons cell death. Because play essential roles lipid metabolism, explored heterogeneity astrocytic states both protoplasmic fibrous-like (CD44+) astrocytes. Significantly, one state showed high levels metallothioneins was distinct striatal neuronal populations. When modeled vitro, improved viability HD-patient-derived spiny projection neurons. Our findings uncover key protecting against HD. is a neurodegenerative shows vulnerability. Here, authors show postmortem brain are regionally diverse, disease-associated cortical compensatory mitigated neural

Language: Английский

Citations

4

Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives DOI Creative Commons
Ching‐Pang Chang,

Ching-Wen Wu,

Yijuang Chern

et al.

Neurobiology of Disease, Journal Year: 2024, Volume and Issue: unknown, P. 106672 - 106672

Published: Sept. 1, 2024

Language: Английский

Citations

4

The Rise of Pluripotent Stem Cell-Derived Glia Models of Neuroinflammation DOI Creative Commons
Srishti Kala, Andrew G. Strutz, Moriah E. Katt

et al.

Neurology International, Journal Year: 2025, Volume and Issue: 17(1), P. 6 - 6

Published: Jan. 13, 2025

Neuroinflammation is a blanket term that describes the body’s complex inflammatory response in central nervous system (CNS). It encompasses phenotype shift to proinflammatory state, release of cytokines, recruitment peripheral immune cells, and wide variety other processes. has been implicated nearly every major CNS disease ranging from Alzheimer’s brain cancer. Understanding modeling neuroinflammation critical for identification novel therapeutic targets treatment diseases. Unfortunately, translation findings non-human models left much be desired. This review systematically discusses role human pluripotent stem cell (hPSC)-derived glia supporting cells within CNS, including astrocytes, microglia, oligodendrocyte precursor pericytes, endothelial describe state field hope future discoveries. hPSC-derived offer an expanded potential study pathobiology immunomodulatory cascades impact progression. While progress made development models, there explore application these understand CNS.

Language: Английский

Citations

0